You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 6, December 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

2,6-Dimethoxyphenol Penicillin in Infants and Children

Preliminary Studies

PAUL A. DAY, M.D.; WINIFRED OSBORN; HOWARD L. WEINBERGER, M.D.; WILLIAM MESIBOV; HENRY ROBIDOUX; PAUL F. WEHRLE, M.D.

Am J Dis Child. 1961;102(6):785-792.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The control and treatment of disease due to staphylococci still present a serious medical problem in spite of the availability of many effective antibacterial agents. This is particularly true in the newborn nursery. With improved hygiene, better regulation of nurseries, and the use of potent antibiotics, staphylococcal infection still occurs with considerable frequency. Difficulties in the control of this infection lie both in the facility with which the organism is transmitted as well as in the variable antibiotic resistance patterns observed with hospital strains. Numerous studies and reviews of the epidemiology and bacteriology of nursery-acquired staphylococcal infections have appeared in the literature.1-12

A new derivative of penicillanic acid, 2,6-dimethoxyphenyl penicillin, appears to inhibit the growth, in vitro, of staphylococci resistant to penicillin G.13 Since this isomer is well absorbed on parenteral administration and has been shown to be nontoxic in animals, it appears to offer considerable promise in . . . [Full Text PDF of this Article]


Author Affiliations

SYRACUSE, N.Y.

Paul A. Day, M.D., Department of Microbiology, State University of New York, Upstate Medical Center, 766 Irving Ave., Syracuse 10, N.Y.; From the Departments of Pediatrics and Microbiology, State University of New York Upstate Medical Center.


Footnotes

Submitted for publication Feb. 17, 1961.

Present address of Dr. Wehrle is Communicable Disease Division, Los Angeles County General Hospital, 1200 N. State Street, Los Angeles 33, Calif.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.